Abstract:Initiation of allergic airway pathology often depends on the protease activity of the inhaled allergen. Previous studies have shown that IL-17–driven neutrophil and eosinophil responses can promote allergic pathology1Kim J. Chang Y. Bae B. Sohn K.H. Cho S.H. Chung D.H. et al.Innate immune crosstalk in asthmatic airways: innate lymphoid cells coordinate polarization of lung macrophages.J Allergy Clin Immunol. 2019; 143: 1769-1782.e11Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar and are associated with an initial epithelial release of IL-23, which is accepted as important in promoting TH17 and group 3 innate lymphoid cell (ILC3) responses. ILC3s are a developmentally and phenotypically diverse innate lymphoid cell (ILC) subset that includes natural killer (NK) cell receptor (NCR)-positive and NCR-negative populations (NCR+ ILC3s and NCR– ILC3s) as well as CCR6+ lymphoid tissue inducer cells. However, all ILC3s are defined by expression of transcript variant 2 of RORC, encoding retinoid-related orphan receptor γt (RoRγt) and production of IL-17 and IL-22.1Kim J. Chang Y. Bae B. Sohn K.H. Cho S.H. Chung D.H. et al.Innate immune crosstalk in asthmatic airways: innate lymphoid cells coordinate polarization of lung macrophages.J Allergy Clin Immunol. 2019; 143: 1769-1782.e11Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar,2Ardain A. Domingo-Gonzalez R. Das S. Kazer S.W. Howard N.C. Singh A. et al.Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.Nature. 2019; 570: 528-532Crossref PubMed Scopus (95) Google Scholar Work carried out in murine models has resulted in ILC3s emerging as critical regulators of infectious2Ardain A. Domingo-Gonzalez R. Das S. Kazer S.W. Howard N.C. Singh A. et al.Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.Nature. 2019; 570: 528-532Crossref PubMed Scopus (95) Google Scholar and noninfectious1Kim J. Chang Y. Bae B. Sohn K.H. Cho S.H. Chung D.H. et al.Innate immune crosstalk in asthmatic airways: innate lymphoid cells coordinate polarization of lung macrophages.J Allergy Clin Immunol. 2019; 143: 1769-1782.e11Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar pulmonary diseases despite ILC3s representing only a minor lung immune cell population in mice. In contrast, ILC3s are the major ILC population in the human lung.3De Grove K.C. Provoost S. Verhamme F.M. Bracke K.R. Joos G.F. Maes T. et al.Characterization and quantification of innate lymphoid cell subsets in human lung.PLoS One. 2016; 11e0145961Crossref PubMed Scopus (96) Google Scholar Importantly, ILC3-associated preclinical phenotypes are reflective of observations in humans.2Ardain A. Domingo-Gonzalez R. Das S. Kazer S.W. Howard N.C. Singh A. et al.Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.Nature. 2019; 570: 528-532Crossref PubMed Scopus (95) Google Scholar,4Jonckheere A.C. Bullens D.M.A. Seys S.F. Innate lymphoid cells in asthma: pathophysiological insights from murine models to human asthma phenotypes.Curr Opin Allergy Clin Immunol. 2019; 19: 53-60Crossref PubMed Scopus (21) Google Scholar However, our understanding of the molecular machinery enabling ILC3s to exact their influence on lung immunity is incomplete. In this study, we have demonstrated that expansion of lung ILC3s occurs in response to the protease papain and that these cells promote an IL-17–associated lung pathology. Critically, we have shown that induction of papain-driven pathology is strongly associated with ILC3 synthesis of acetylcholine (ACh). We have previously identified ACh responsiveness by immune cells in the lung as being important for CD4+ T-cell–driven adaptive immunity to Nippostrongylus brasiliensis infection.5Darby M. Schnoeller C. Vira A. Culley F.J. Bobat S. Logan E. et al.The M3 muscarinic receptor is required for optimal adaptive immunity to helminth and bacterial infection.PLoS Pathog. 2015; 11e1004636Crossref PubMed Scopus (30) Google Scholar Here, we have extended this insight by demonstrating that ACh from lineage-negative (Lin–) CD127+ lymphocytes expressing RoRγt is instrumental for promoting protease induction of allergic inflammation. This identifies a new paradigm for how ILC3s and ACh contribute to early promotion of allergic pathology that is distinct from our traditional understanding of ACh-driven neuromuscular interactions causing allergic pulmonary airway resistance. We have identified association of ILC3s with protease-induced lung pathology following acute papain challenge of wild-type (WT) C57BL/6 mice. Papain challenge increased lung concentrations of IL-13, IL-17A, IL-22, and IL-23 in comparison with the concentrations in saline-challenged mice (Fig 1, A). IL-17– and IL-23–promoted pathology suggests a RoRγt-driven inflammation. Papain challenge of RoRγt–green fluorescent protein (GFP) reporter mice demonstrated a significant expansion of the numbers of ILC3s (Lin–CD45+CD127+ICOS–RoRγt-GFP+), group 2 ILCs (ILC2s) (Lin–CD45+CD127+ICOS+RoRγt-GFP–), and CD3+CD4+ RoRγt-GFP+ T cells relative to the numbers in saline-treated controls (Fig 1, B and see Fig E1 in this article's Online Repository at www.jacionline.org). Restimulation and intracellular cytokine capture of lung CD4+ T cells from papain-challenged mice detected increased levels of IL-5 and IL-13 but not IL-17 when compared with the levels in saline-treated controls (Fig 1, C). However, in CD45+CD3–Lin– cells, in addition to increased levels of IL-5 and IL-13, a raised IL-17 level was detected in papain-challenged mice when compared with the levels in saline-treated controls (Fig 1, C). Moreover, anti-CD3 depletion of T cells did not protect against and in fact promoted papain-driven pathology (see Fig E2 in this article's Online Repository at www.jacionline.org). These findings support IL-17–driven pathology as being independent of RoRγt+ TH17 T-cell IL-17 production. To test a requirement for any T-cell (and B-cell) contribution to IL-23/IL-17–promoted pathology, we challenged RAG2–/– mice with papain in the presence or absence of an IL-23–neutralizing mAb (anti–IL-23) (Fig 1, D). Decreased lung inflammation in IL-23–depleted RAG2–/– mice was revealed by histologic analysis as well as by reduced detection of Evans blue (EB) leakage into bronchoalveolar lavage fluid (BALF) (Fig 1, D) when compared with that in isotype-treated RAG2–/– mice. BALF immune cell infiltration was reduced in all immune cell populations, and tissue levels of IL-17A (but not IL-13) were lower in the IL-23–depleted RAG2–/– mice (Fig 1, D). This abrogation of papain-induced allergic inflammation in anti–IL-23–treated RAG2–/– mice supports ILC3s as being a key contributing lymphoid cell population driving protease-mediated lung inflammation. To further characterize the input of ILC3s to allergic airway pathology, we compared pulmonary responses to papain in WT and Rorc–/– mice (Fig 1, E). Rorc–/– mice did not show significant baseline differences from C57Bl/6 mice in terms of BALF cell composition (see Fig E3 in this article's Online Repository at www.jacionline.org), but histologic analysis of lung sections revealed decreased inflammation and detection of EB leakage into the BALF in Rorc–/– mice challenged with papain versus in WT mice (Fig 1, E). Total BALF immune cell infiltration was also reduced for all immune cell populations (Fig 1, E). Moreover, detection of both IL-13 and IL-17A, as well as IL-22, was reduced in Rorc–/– mice (Fig 1, E). In agreement with findings by others6Lim A.I. Li Y. Lopez-Lastra S. Stadhouders R. Paul F. Casrouge A. et al.Systemic human ILC precursors provide a substrate for tissue ILC differentiation.Cell. 2017; 168: 1086-1100.e10Abstract Full Text Full Text PDF PubMed Scopus (299) Google Scholar Rorc–/– mice had expanded numbers of ILC2s (Lin–CD45+CD127+ICOS+) when compared with the numbers in WT mice (Fig 1, E). However, as expected, detection of ILC3 subsets such as NCR+ ILC3s (Lin–CD45+CD127+ICOS–NKp46+) in Rorc–/– mice was acutely reduced as opposed to in WT mice; the small number of cells detected were most likely to be non-NK, non–RoRγt-expressing group 1 ILCs (ILC1s). This body of work identifies a previously unappreciated, T-cell–independent role for IL-23–responsive ILC3s in contributing to the onset of papain-driven lung pathology. An additional striking feature of these results was protection from cholinergic-promoted airway resistance during papain challenge in the absence of Rorc expression (Fig 1, E). Lymphocytes are important responders to, and sources of, neurotransmitters. For example, the ILC2 response to the neurotransmitter neuromedin U is critical for inducing type 2 immunity,7Cardoso V. Chesne J. Ribeiro H. Garcia-Cassani B. Carvalho T. Bouchery T. et al.Neuronal regulation of type 2 innate lymphoid cells via neuromedin U.Nature. 2017; 549: 277-281Crossref PubMed Scopus (305) Google Scholar and production of ACh by immune cells following type 2 immune challenge can promote host type 2 immune responses.8Roberts L.B. The influence of non-neuronal cholinergic signalling on the type 2 immune response. Imperial College London, London, UK2017Google Scholar Moreover, ACh-producing T cells can contribute to control of chronic viral infection,9Cox M.A. Duncan G.S. Lin G.H.Y. Steinberg B.E. Yu L.X. Brenner D. et al.Choline acetyltransferase-expressing T cells are required to control chronic viral infection.Science. 2019; 363: 639-644Crossref PubMed Scopus (45) Google Scholar and CD4+ T-cell responses to ACh via the M3 muscarinic receptor are required for optimal adaptive immunity to helminth and bacterial infections.5Darby M. Schnoeller C. Vira A. Culley F.J. Bobat S. Logan E. et al.The M3 muscarinic receptor is required for optimal adaptive immunity to helminth and bacterial infection.PLoS Pathog. 2015; 11e1004636Crossref PubMed Scopus (30) Google Scholar In the spleen, lymphocytes are major effectors of the cholinergic anti-inflammatory pathway through their synthesis and release of ACh, which downregulates inflammation. ILC3 responses to cholinergic stimulation can also contribute to the cholinergic anti-inflammatory pathway by regulating neutrophilia in sepsis models. However, whether ILC3s themselves may be an immune cell–derived source of ACh capable of regulating immunity has not previously been investigated. To identify whether lung ILC3s may produce ACh during acute protease-induced inflammation, we challenged ChAT(BAC)-eGFP reporter mice with papain. In addition to increased choline acetyltransferase (ChAT) production by CD3+CD4+ cells (and a trend toward increased production by Lin–CD45+CD127+ICOS+ ILC2s), we identified an increase in the ChAT-expressing ILC3-enriched (Lin–CD45+CD127+ICOS–) population, but with no effect on the number of NK (CD3–DX5+) cells in the lungs of papain-challenged mice (Fig 2, A). Therefore, RoRγt-expressing ILC3s increase synthesis of ACh following papain challenge. To test whether ILC3 synthesis of ACh contributes to papain-driven pathology, we generated RoRγtCreChATloxp mice. These mice lack the ability to generate ACh following deletion of ChAT in RoRγt-expressing cells. Papain challenge of RoRγtCreChATloxp mice resulted in decreased histologic detection of inflammation and vascular leakage of EB in BALF compared with in the BALF of ChATloxp mice (Fig 2, B), along with reduced methacholine-induced airway resistance and reduced numbers of neutrophils and eosinophils in the BALF (Fig 2, B). Detection of cytokines in lung homogenates identified reduced IL-13 and IL-17A levels as well as reduced IL-22 levels, in RoRγtCreChATloxp mice as compared with in the controls (Fig 2, B). Therefore, disruption of ChAT in RoRγt+ cells was sufficient to recapitulate the reduced pathology seen in papain-challenged Rorc–/– mice (Fig 1). Quantification of ILCs revealed equivalent ILC2 (Lin–CD45+CD127+ICOS+) numbers but decreased NCR+ ILC3 (Lin–CD45+CD127+ICOS–NKp46+) numbers between papain-challenged WT and RoRγtCreChATloxp mice (Fig 2, B). An equivalent phenotype was demonstrated following Alternaria alternata extract–driven acute allergic inflammation (Fig 2, C). As with papain, A alternata extract challenge of RoRγtCreChATloxp mice resulted in decreased histologic detection of inflammation and vascular leakage of EB in BALF along with reduced methacholine-induced airway resistance, reduced numbers of neutrophils and eosinophils in the BALF, and reduced detection of IL-13 and IL-17A in lung homogenates compared with in ChATloxp mice (Fig 2, C). In summary, following acute protease challenge, we found raised IL-13, IL-23, IL-22, and IL-17A expression in the lung and increased numbers of ILC3s. Papain challenge did not induce elevated CD4+ T-cell IL-17 levels irrespective of raised RoRγt+CD4+ T-cell numbers. Moreover, in the absence of T cells, papain-induced lung inflammation was maintained but abrogated when IL-23 or RoRγt function was disrupted. This strongly supports ILC3 expansion in the lung as a driving factor in IL-17–associated inflammation following an acute protease lung challenge. Reduction in airway cholinergic responsiveness led us to investigate whether ILC3s were a physiologically relevant source of ACh following papain challenge. We tested this by generating RoRγtCreChATloxp mice that lack the ability to generate ACh in RoRγt-expressing cells. Remarkably, this ILC3-biased disruption of ChAT expression protected against pathology to an extent equivalent to that seen in Rorc–/– mice. This identifies RoRγt+ cell expression of ChAT as an important component in the promotion of protease-mediated allergic lung pathology. Indeed, these data support ILC3s expressing ACh as playing a central role in initiation of the IL-17–promoted allergic inflammatory cascade. These findings place ILC3 synthesis of ACh as a central requirement for allergic lung inflammation, adding a critical new paradigm to our understanding of cholinergic responses in driving allergic lung inflammation and pathology. We would like to acknowledge Elodie Culerier for her technical assistance and Marc Le Bert (INEM UMR7355 Experimental and Molecular Immunology and Neurogenetics, CNRS and University of Orleans) for expert advice on mouse genetics. All mice used in this study were 6- to 12-week-old C57BL/6 background mice. The mouse strains used were C57BL/6, RAG2–/–, ChAT(BAC)-eGFP,E1Tallini Y.N. Shui B. Greene K.S. Deng K.Y. Doran R. Fisher P.J. et al.BAC transgenic mice express enhanced green fluorescent protein in central and peripheral cholinergic neurons.Physiol Genomics. 2006; 27: 391-397Crossref PubMed Scopus (129) Google Scholar RoRγt-eGFP,E2Eberl G. Marmon S. Sunshine M.J. Rennert PD, Choi Y, Littman DR. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells.Nat Immunol. 2004; 5: 64-73Crossref PubMed Scopus (778) Google Scholar RoRγt-KO (Rorc–/–),E3Sun Z. Unutmaz D. Zou Y.R. Sunshine M.J. Pierani A. Brenner-Morton S. et al.Requirement for RORgamma in thymocyte survival and lymphoid organ development.Science. 2000; 288: 2369-2373Crossref PubMed Scopus (588) Google Scholar, E4Eberl G. Littman D.R. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells.Science. 2004; 305: 248-251Crossref PubMed Scopus (402) Google Scholar RoRγtCre,E3Sun Z. Unutmaz D. Zou Y.R. Sunshine M.J. Pierani A. Brenner-Morton S. et al.Requirement for RORgamma in thymocyte survival and lymphoid organ development.Science. 2000; 288: 2369-2373Crossref PubMed Scopus (588) Google Scholar and ChATloxp.E5Misgeld T. Burgess R.W. Lewis R.M. Cunningham J.M. Lichtman J.W. Sanes J.R. Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase.Neuron. 2002; 36: 635-648Abstract Full Text Full Text PDF PubMed Scopus (248) Google Scholar Rorc–/– mice are deficient in expression of transcript variant 2 of RORC, encoding RoRγt. RoRγt is necessary for the development of lymph nodes and Peyer patches, which fail to develop in Rorc–/– mice.E4Eberl G. Littman D.R. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells.Science. 2004; 305: 248-251Crossref PubMed Scopus (402) Google Scholar RoRγt is expressed by many cells, including immature double-positive (CD4+CD8+) αβ thymocytes, RoRγt+ TH17 T cells, and ILC3s, which comprise NCR+ ILC3s and NCR– ILC3s, as well as CCR6+ lymphoid tissue inducer cells. RoRγtCre and ChATloxp mice were crossed over 5 generations to generate RoRγtCreChATfl mice. The ChAT(BAC)-eGFP mouse has been demonstrated to faithfully report ChAT expression and ACh synthesis capacity across a number of hematopoietic immune cell types.E1Tallini Y.N. Shui B. Greene K.S. Deng K.Y. Doran R. Fisher P.J. et al.BAC transgenic mice express enhanced green fluorescent protein in central and peripheral cholinergic neurons.Physiol Genomics. 2006; 27: 391-397Crossref PubMed Scopus (129) Google Scholar As the major rate-limiting enzyme of crucial significance for ACh synthesis, demonstration of ChAT expression by a specific cell type is widely considered to reflect the cholinergic-synthesizing nature of the cell. The mice were anesthetized by isoflurane followed by intranasal administration of 25 μg of papain (Calbiochem, Darmstadt, Germany) in 40 μL of saline solution per mouse once per day on days 1, 2, and 3. On day 4 mice, were humanely killed by CO2 inhalation 24 hours after the final administration of papain. A alternata extract was administered daily for 3 days at a dose of 25 μg per mouse by the endotracheal route under light isoflurane anaesthesia, before the mice were humanely killed on day 4 by CO2 inhalation. Anti–IL-23 antibody or isotype control (Bio X cell, Lebanon, NH; BR0313 or rat IgG1) was given daily 1 hour before papain challenge at a dose of 200 μg per mouse via the endotracheal route. Anti-CD3 (Biolegend, San Diego, Calif; catalog no. BL100208) antibody or isotype controls was given via intraperitoneal injection daily 1 hour before papain challenge at a rate of 50 μg per mouse. After the mice were humanely killed, BALF was collected before cardiac perfusion with ISOTON II (acid-free balanced electrolyte solution, Beckman Coulter, Krefeld, Germany), after which the lungs were collected and sampled for analyses. All of the animal experimental protocols complied with French ethical and animal experiments regulations (see Charte Nationale, Code Rural R 214-122, 214-124 and European Union Directive 86/609/EEC) and were approved by the Ethics Committee for Animal Experimentation of CNRS Campus Orleans, registered (No. 3) by the French National Committee of Ethical Reflexion for Animal Experimentation (CLE CNRS Campus Orleans 2013-1006). All of the South African experiments were carried out in accordance with South African Veterinary Council regulations and were approved by the University of Cape Town Faculty of Health Sciences Animal Ethics Committee. The left lobe of lung was fixed in 4% buffered formaldehyde and paraffin embedded under standard conditions. Tissue sections (3-μm) were stained with standard hematoxylin and eosin and periodic acid–Schiff. The histologic score of the pathology was determined by a semiquantitative assessment on a scale of 0 to 5 for cell infiltration (with increasing extent). The slides were blindly examined by 2 investigators with a Leica microscope (Leica, Solms, Germany). Bronchoalveolar lavage was performed by 4 lavages of lung with 500 μL of saline solution via a cannula introduced into the mouse trachea. BALF samples were centrifuged at 400 g for 10 minutes at 4°C, the supernatants were stored at –20°C for analysis, and pellets were recovered to prepare Cytospin (Thermo Scientific, Waltham, Mass) on glass slides followed by staining with Diff-Quik stain (Merz & Dade AG, Dudingen, Switzerland). Differential cell counts were performed with at least 300 cells. Vascular leakage was quantified by protein and EB concentration in the BALF. EB in BALF was measured 45 minutes after intravenous injection of 0.3% EB; the measurement was performed by absorbance at 460 nm, as described elsewhere.E6Michaudel C. Mackowiak C. Maillet I. Fauconnier L. Akdis C.A. Sokolowska M. et al.Ozone exposure induces respiratory barrier biphasic injury and inflammation controlled by IL-33.J Allergy Clin Immunol. 2018; 142: 942-958Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar Extravasation was expressed as micrograms of EB per milliliter (μg of EB/mL) of BALF supernatant. Lungs were digested in RPMI 1640 medium containing 100 U/mL of penicillin, 100 U/mL of streptomycin, 1 mg/mL of DNase I (Sigma, St Louis, Mo), and 125 μg of liberase (Roche, Basel, Switzerland) for 1 hour at 37°C under rotation. After digestion, RPMI 1640 medium supplemented with 10% FCS was added. Cells were dissociated by passage through a 70-μm cell strainer and centrifuged at 400 g for 5 minutes at 4°C. Pellets were resuspended in red blood cell lysis buffer (Stem Cell Technologies, Vancouver, British Columbia, Canada) and incubated for 10 minutes on ice. Lysis was stopped by addition of RPMI 1640 medium and centrifuged again at 400 g for 5 minutes at 4°C. Pellets were resuspended in RPMI 1640 medium supplemented with 10% FCS and passed through a 40-μm cell strainer. ILC2s were identified by using a Lin cocktail, CD45, CD127, and ICOS panel. ILC3s were identified by using a panel containing a Lin cocktail, CD45, CD127, ICOS, and NKp46 or RoRγt, as indicated. Cytokine-expressing T cells were identified by using a panel containing CD3, CD4, IL-5, IL-13, or IL-17, as indicated. NK cells were identified by using a panel containing CD3 and DX5. All FACS antibodies were from Biolegend. Homogenized lungs were tested for IL-13 and IL-17 by using commercial ELISA kits (eBiosciences, San Diego, Calif) according to the manufacturer's instructions. For invasive measurement of dynamic resistance, mice were anesthetized by intraperitoneal injection of solution containing ketamine (100 mg/kg, Merial, Duluth, Ga) and xylazine (10 mg/kg, Bayer, Leverkusen, Germany), paralyzed by using D-tubocuranine (0.125%, Sigma), and intubated with an 18-gauge catheter. Respiratory frequency was set at 140 breaths per minute with a tidal volume of 0.2 mL and a positive end-expiratory pressure of 2 mL of H2O. Increasing concentrations of aerosolized methacholine (9.375, 18.75, 37.5, 75, and 150 mg/mL) were administered. Resistance was recorded by using an invasive plethysmograph (Buxco, London, United Kingdom). Baseline resistance was restored before administration of the subsequent doses of methacholine.E7Madouri F. Chenuet P. Beuraud C. Fauconnier L. Marchiol T. Rouxel N. et al.Protein kinase Ctheta controls type 2 innate lymphoid cell and TH2 responses to house dust mite allergen.J Allergy Clin Immunol. 2017; 139: 1650-1666Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar Data were analyzed by using Prism software, version 5 or 6 (GraphPad Software, San Diego, Calif). Either a Mann-Whitney t test or the parametric 1-way ANOVA test with Bonferroni multiple-comparison was used to assess significance. Values are expressed as means ± SDs.Fig E2CD3-depleted ChAT-GFP mice do not show reduced inflammation to papain. Mice were treated daily with anti-CD3 antibody administered intraperitoneally 1 hour before papain challenge at a dose of 50 μg/mouse. BALF cellular infiltration was assessed 24 hours after final administration of papain. BAL, Bronchoalveolar lavage fluid; Eos., eosinophil; Gra., granulocyte; Lymp, lymphocyte; Mono., monocyte.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Fig E3Rorc–/– mice do not show significant baseline differences from C57Bl/6 mice in terms of BALF cell composition. BALF immune cell infiltration and levels of lung ILC2s (Lin–CD45+CD127+ICOS+) and NCR+ ILC3s (Lin–CD45+CD127+ICOS–NKp46+) in saline-treated C57Bl/6 and Rorc–/– mice were analyzed by flow cytometry. BAL, Bronchoalveolar lavage fluid; Eos., eosinophil; Gra., granulocyte; Lymp, lymphocyte; Mono., monocyte.View Large Image Figure ViewerDownload Hi-res image Download (PPT)

Abstract:In this issue, Imai et al. (2019) provide new insights into the pathophysiology of AD-like inflammation using their model (Imai et al., 2013) and ask how ILC2s and basophils contribute to the IL-33–induced AD-like inflammation. Their findings show that continuous expression of IL-33 in keratinocytes is sufficient to cause AD-like inflammation in mice, and that this occurrence is largely independent of adaptive immune cells and is mediated by basophils and ILC2s. In this issue, Imai et al. (2019) provide new insights into the pathophysiology of AD-like inflammation using their model (Imai et al., 2013) and ask how ILC2s and basophils contribute to the IL-33–induced AD-like inflammation. Their findings show that continuous expression of IL-33 in keratinocytes is sufficient to cause AD-like inflammation in mice, and that this occurrence is largely independent of adaptive immune cells and is mediated by basophils and ILC2s. Clinical Implications•IL-33–driven AD is independent of adaptive immunity.•Keratinocyte-derived IL-33 activates basophils, which induce ILC2s.•Basophil depletion in this context is of potential therapeutic interest.Atopic dermatitis (AD) is an important clinical disease with different, often severe, manifestations. Causative agents may include chemicals of environmental or plant origin; genetic predisposition factors are also relevant (Weidinger and Novak, 2016Weidinger S. Novak N. Atopic dermatitis.Lancet. 2016; 387: 1109-1122Abstract Full Text Full Text PDF PubMed Scopus (1154) Google Scholar). Mechanistic insights may be obtained from mouse models (Nakajima et al., 2019Nakajima S. Nomura T. Common J. Kabashima K. Insights into atopic dermatitis gained from genetically defined mouse models.J Allergy Clin Immunol. 2019; 143: 13-25Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar). Experimentally, AD can be induced by the topical application of proteins, chemicals, inflammatory cytokines, histamines, and other mediators that distort the epithelial immune microenvironment (Dainichi et al., 2018Dainichi T. Kitoh A. Otsuka A. Nakajima S. Nomura T. Kaplan D.H. et al.The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis.Nat Immunol. 2018; 19: 1286-1298Crossref PubMed Scopus (173) Google Scholar). IL-33 is a pleiotropic cytokine playing a pivotal role in allergic disorders, including AD (Liew et al., 2016Liew F.Y. Girard J.P. Turnquist H.R. Interleukin-33 in health and disease.Nat Rev Immunol. 2016; 16: 676-689Crossref PubMed Scopus (625) Google Scholar). Intradermal injection of IL-33 in the skin caused psoriasis-like neutrophilic inflammation with mast cell activation in mice (Hueber et al., 2011Hueber A.J. Alves-Filho J.C. Asquith D.L. Michels C. Millar N.L. Reilly J.H. et al.IL-33 induces skin inflammation with mast cell and neutrophil activation.Eur J Immunol. 2011; 41: 2229-2237Crossref PubMed Scopus (135) Google Scholar). Topical application of calcipotriol (a vitamin D3 analogue) induces expression of thymic stromal lymphopoietin (Li et al., 2006Li M. Hener P. Zhang Z. Kato S. Metzger D. Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.Proc Natl Acad Sci USA. 2006; 103: 11736-11741Crossref PubMed Scopus (356) Google Scholar) and causes IL-33–dependent AD-like inflammation involving dendritic cell activation with a distinct type 2 immune response (Li et al., 2017Li C. Maillet I. Mackowiak C. Viala C. Di Padova F. Li M. et al.Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells.Cell Death Dis. 2017; 8: e2735Crossref PubMed Scopus (41) Google Scholar). •IL-33–driven AD is independent of adaptive immunity.•Keratinocyte-derived IL-33 activates basophils, which induce ILC2s.•Basophil depletion in this context is of potential therapeutic interest. Imai et al., 2013Imai Y. Yasuda K. Sakaguchi Y. Haneda T. Mizutani H. Yoshimoto T. et al.Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.Proc Natl Acad Sci USA. 2013; 110: 13921-13926Crossref PubMed Scopus (323) Google Scholar established a transgenic mouse expressing IL-33 in keratinocytes driven by the keratin-14 promoter (IL33tg) that is characterized by epidermal hyperkeratosis as well as eosinophil and innate lymphoid cell type 2 (ILC2) infiltration. Now, the authors provide new insights into the pathophysiology of AD-like inflammation using their model (Imai et al., 2013Imai Y. Yasuda K. Sakaguchi Y. Haneda T. Mizutani H. Yoshimoto T. et al.Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.Proc Natl Acad Sci USA. 2013; 110: 13921-13926Crossref PubMed Scopus (323) Google Scholar) and ask how ILC2s and basophils contribute to the IL-33–induced AD-like inflammation (Imai et al., 2019Imai Y. Yasuda K. Nagai M. Kusakabe M. Kubo M. Nakanishi K. et al.IL-33–induced atopic dermatitis–like inflammation in mice is mediated by group 2 innate lymphoid cells in concert with basophils.J Invest Dermatol. 2019; 139: 2185-2194Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar). Skin inflammation developed in B cell– and T cell–deficient Rag2KO IL33tg mice suggests that adaptive immune cells are dispensable. In contrast, the depletion of ILC2s accomplished via bone marrow transplantation from IL33tg to ILC2-lacking, RORα-deficient mice suppressed the development of AD-like inflammation. The authors then explored the role of the basophils in IL33tg skin inflammation. Specific depletion of basophils with the anti-FcεRIα antibody MAR1 (Sokol et al., 2008Sokol C.L. Barton G.M. Farr A.G. Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses.Nat Immunol. 2008; 9: 310-318Crossref PubMed Scopus (760) Google Scholar), or conditional diphtheria toxin–induced basophil depletion using Bas-TRECK mice (Sawaguchi et al., 2012Sawaguchi M. Tanaka S. Nakatani Y. Harada Y. Mukai K. Matsunaga Y. et al.Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness.J Immunol. 2012; 188: 1809-1818Crossref PubMed Scopus (133) Google Scholar) crossed with the IL33tg mice, reduced AD-like inflammation. These results provide strong support for a critical role of basophils in this model, consistent with a previous report (Nakashima et al., 2018Nakashima C. Otsuka A. Kabashima K. Recent advancement in the mechanism of basophil activation.J Dermatol Sci. 2018; 91: 3-8Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar). Moreover, the authors demonstrated that depletion of basophils in IL33tg skin reduces the accumulation of ILC2s and ILC2-derived cytokines and chemokines, including IL-5, IL-13, and CCL5. Therefore, the data suggest that keratinocyte-driven, IL-33–mediated AD-like inflammation may be initially and solely dependent on an innate immune response mediated by ILC2s acting in concert with basophils (Figure 1). The study is of interest because it shows that continuous expression of IL-33 in keratinocytes is sufficient to cause AD-like inflammation in mice, and that this occurrence is largely independent of adaptive immune cells and is mediated by basophils and ILC2s. ILC2s have emerged as important participants in early allergic responses in skin that pave the way for T helper type 2 cell responses. However, the observation that basophils are required for the ILC2 differentiation is novel and thus may open new therapeutic considerations. There are limitations of this model, because the mechanisms explored involve IL-33 production that is restricted to keratinocytes. AD in patients clearly depends on other inflammatory factors and cell types. In addition, RORα-dependent ILC2 depletion may affect cytokine production from group 3 innate lymphoid cells and T helper type 17 cells (Lo et al., 2016Lo B.C. Gold M.J. Hughes M.R. Antignano F. Valdez Y. Zaph C. et al.The orphan nuclear receptor ROR alpha and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease.Sci Immunol. 2016; 1: eaaf8864Crossref Scopus (54) Google Scholar). The roles of basophils and ILC2s should be investigated additionally in other experimental models of AD and in patients. IL-33–Induced Atopic Dermatitis–Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with BasophilsJournal of Investigative DermatologyVol. 139Issue 10PreviewIL-33 is a proinflammatory cytokine that plays a pivotal role in allergic disorders. In a transgenic mouse expressing IL-33 driven by a keratin-14 promoter (IL33tg), atopic dermatitis (AD)-like inflammation develops spontaneously with the activation of group 2 innate lymphoid cells (ILC2s). However, it remains unknown how effector cells, such as T helper type 2 cells, ILC2s, and basophils, contribute to the inflammatory process induced by IL-33. To address the question, we examined the phenotype of IL33tg mice lacking each of these cells. Full-Text PDF Open Archive

IL-17 Initiates Tertiary Lymphoid Organ Formation

Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection

IL-17 Regulate the Polarization of Macrophages to Promote the Development of Obliterative Bronchiolitis in Murine Trachea Transplantation Model

LTi-like type 3 innate lymphoid cells are associated with the transient induction of tertiary lymphoid structures in inflamed pulmonary tissue

IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs

IL-25 Regulates the Polarization of Macrophages and Attenuates Obliterative Bronchiolitis in Murine Trachea Transplantation Models.

IL-17–producing ST2+ Group 2 Innate Lymphoid Cells Play a Pathogenic Role in Lung Inflammation

BLT1-dependent Alveolar Recruitment of CD4(+)CD25(+) Foxp3(+) Regulatory T Cells is Important for Resolution of Acute Lung Injury.

The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.

The Origin and Role of Innate Lymphoid Cells in the Lung

Sustained innate interferon is an essential inducer of tertiary lymphoid structures

Chronic Inflammation: A Common Promoter in Tertiary Lymphoid Organ Neogenesis

Human Lung Conventional Dendritic Cells Orchestrate Lymphoid Neogenesis during Chronic Obstructive Pulmonary Disease

IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB

Innate lymphoid cells — how did we miss them?

ILC3-derived Acetylcholine Promotes Protease-Driven Allergic Lung Pathology

Absence of sympathetic innervation hampers the generation of tertiary lymphoid structures upon acute lung inflammation

ILC2s and Basophils Team Up to Orchestrate IL-33–Induced Atopic Dermatitis

Lymphotoxin-Dependent Control of Intestinal Inflammation

Lipid droplet messengers

IL-17 Contributes to the Pathogenesis of Obliterative Bronchiolitis Via Regulation of M1 Macrophages Polarization in Murine Heterotopic Trachea Transplantation Models.